Weiss Multi-Strategy Advisers’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
Other funds holding AERI
WP
PHS
Weiss Multi-Strategy Advisers's AERI Position: Q1 2021 in Review
Weiss Multi-Strategy Advisers sold out of Aerie Pharmaceuticals (AERI) in Q1 2021, closing a stake of 10,452 shares — an estimated $141K sold.
Weiss Multi-Strategy Advisers first reported a position in AERI in Q1 2015 and held it in 18 quarters. The position peaked at $3.29M in Q4 2017. 158 funds tracked by Wall St. Rank hold AERI as of Q1 2021.
- Weiss Multi-Strategy Advisers reported no remaining Aerie Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
- Weiss Multi-Strategy Advisers sold 10,452 Aerie Pharmaceuticals shares in Q1 2021, an estimated $141K.
- Weiss Multi-Strategy Advisers first reported a position in Aerie Pharmaceuticals in Q1 2015 and held it in 18 quarters.
- Weiss Multi-Strategy Advisers's Aerie Pharmaceuticals position peaked at $3.29M in Q4 2017.
- 158 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2021.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2021, filed 14 May 2021.